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Tuberculosis in
Undocumented
Migrants, Geneva 
To the Editor: In today’s global-
ized world, a growing number of peo-
ple are migrating in search of a better
life. Simultaneously, industrialized
countries are strengthening border
controls and administrative barriers to
contain this influx of newcomers,
resulting in a significant increase in
illegal migration and human traffick-
ing. The U.S. Department of State
estimates the annual flow of irregular
migrants worldwide to be 700,000–2
million (1). Many of the migrants are
from countries where tuberculosis is
endemic, and they contribute to the
increasing proportion of foreign-born
persons with tuberculosis in North
America and Europe. These persons
may be highly contagious in the local
population, as they have limited
access to healthcare and often go
untreated (2,3). 
Of 450,000 residents in Geneva,
Switzerland, 10,000–20,000 are
undocumented and come from devel-
oping countries or Eastern Europe. All
patients treated for tuberculosis in
Geneva are systematically registered
by the Antituberculosis Center, a
facility at Geneva University
Hospital. An outpatient clinic pro-
vides free consultations for patients
with tuberculosis who have no health
insurance, and patients are not
required to disclose their immigration
status to physicians. Patients with suf-
ficient funds pay for their medication. 
All cases of tuberculosis in undoc-
umented migrants (foreign residents
with no resident permits) reported
from 1994 to 1998 were reviewed by
the same investigator. Their sociode-
mographic and clinical characteristics
were compared with those of 7 South
American legal residents with tuber-
culosis (representing the whole sam-
ple of South American tuberculosis
patients) during the same period and
with those of a group of 50 tuberculo-
sis patients from the general popula-
tion in a previous study. 
From 1994 to 1998, a total of 397
persons in Geneva were notified that
they were infected with tuberculosis.
Twenty-two (6%) case-patients were
found among undocumented
migrants. The mean age was 31 years
(19–48 years), and 20 (91%) were
women; 15 (68%) came from South
America, 5 (22%) came from Africa,
and 2 (9%) came from Europe.
Nineteen (95%) of 20 persons had
symptoms for >1 month preceding
their first medical encounter.
Approximately 27.2% had pulmonary
manifestations only, 36.4% had extra-
pulmonary manifestations only, and
the remaining 36.4% had both pul-
monary and extrapulmonary manifes-
tations.  Mycobacterium tuberculosis
was found in 11 of 14 with pulmonary
involvement, and chest radiograph
was normal in 5 (22%). When com-
pared with patients from the general
population, women were more numer-
ous (91% vs. 30%), and extrapul-
monary tuberculosis was more fre-
quent among undocumented residents
(72% vs. 34%). The time from first
symptoms to first consultation was
also longer when compared to the
general population and the registered
South American residents (5% vs.
30% and 40%, respectively, consult-
ing in the first month; p = 0.008). In 4
(19%) patients, resistance to ≥1 anti-
tuberculosis drug was identified, with
no multidrug resistance (defined as
rifampicin) identified, a rate of resist-
ance similar to that seen in their coun-
tries of origin but higher than the
Swiss rate (6.3%) (4). All patients
were treated with a 4-drug regimen
(HRZE: H = isoniazid, R = rifam-
picin, Z = pyrazinamid, E = ethambu-
tol) for 2 months, followed by a 2-
drug therapy (HR) for 4 months.
Eighteen (82%) patients adhered to
the regimen, as determined by month-
ly medical interviews and urine isoni-
azid checks. Only the 4 remaining
patients who missed more than one
third of the appointments with 50% of
negative urine checks, or who default-
ed, were placed under directly
observed therapy. Fifteen (68%)
patients regularly attended their
appointments until completion of
treatment. Seven (32%) patients left
Switzerland before the end of treat-
ment, 2 of whom were deported. 
Fourteen (64%) patients were hos-
pitalized to initiate treatment. Four
had health insurance; the other
patients contracted a debt for hospital-
ization. The lack of insurance did not
influence adherence to treatment neg-
atively. However, as a consequence of
tuberculosis, 8 (66%) lost their jobs. 
Of 102 identified close contacts,
88 (87%) were evaluated by tuber-
culin skin testing. Chest x-ray was
performed on 21 (24%) patients with
a positive test (>10 mm induration),
and isoniazid was prescribed prophy-
lactically. No secondary case of active
tuberculosis was identified.
Most undocumented immigrants
with tuberculosis in Geneva are young
South American or African women
engaged in domestic activities. This
finding reflects the irregular work
opportunities in Geneva, an area with
little agriculture and industry. As sus-
pected, a delay of several weeks
occurred before seeking care (5). The
economic and social impact of tuber-
culosis was high for this population.
Two thirds of these patients lost their
jobs as a consequence of tuberculosis.
Joblessness could be an additional fac-
tor to further deter patients from seek-
ing care. Adherence to treatment was
good, which suggested confidence that
care providers would not report to
immigration authorities and that sup-
portive follow-up care was available.
Of more concern, approximately one
third of the patients left Switzerland
before completing the full course of
treatment. This transfer rate of undoc-
umented migrants corresponds to that
observed (43%) among foreign-born
patients with unknown legal status in
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Switzerland (6). Failure to complete a
full course of treatment may lead to
relapse and emergence of resistant
strains. A growing proportion of cases
of tuberculosis observed in Europe is
in migrants, some undocumented,
from the developing world (3). Strong
political measures should be enforced
to ensure access to healthcare services
with respect to confidentiality (as
recently stated in the Netherlands) (7).
Much emphasis has been put on
screening at time of arrival. Screening
can be conducted for immigrants and
asylum seekers, but undocumented
migrants are not screened (8).
Facilitated access to medical services
and free affordable therapy is a neces-
sity; active tuberculosis develops in
most foreign-born residents several
years after their arrival (2). In an era of
high mobility, specific innovative pro-
grams should be established to control
and prevent tuberculosis for this high-
risk, foreign-born population. Early
detection with nonidentifying tubercu-
losis tracking systems (9), screening at
unspecialized clinics (10), and free
treatment with adequate administra-
tive measures are needed.
Industrialized countries must take
responsibility to reduce the spread of
resistant tuberculosis. 
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Mycobacterium
chelonae Skin
Infection in Kidney-
Pancreas Recipient
To the Editor: Mycobacterium
chelonae is rapid growing and is ubiq-
uitous in the environment, including
soil, water, domestic and wild ani-
mals, and milk and fruit products. It
can be associated with infections of
the soft tissue, lung, bone, joint, cen-
tral nervous system, and eye. M. che-
lonae infections in an immunocom-
promised host are disseminated in
>50% of those infected; chronic use
of steroids, even in low doses, seems
to be the most important predictive
factor for disseminated disease (1,2).
In immunocompetent hosts, nontuber-
culous mycobacteria can colonize
body surfaces and be secreted for pro-
longed periods without causing dis-
ease. In hematopoietic stem cell and
solid organ transplant recipients,
infections with nontuberculous
mycobacteria are common and may
be a source of illness and death (3).
We describe a case of localized cuta-
neous  M. chelonae infection after a
dog bite in a kidney-pancreas trans-
plant recipient.
A 43-year-old female patient
underwent kidney transplantation for
diabetic nephropathy in 1985. After
loss of organ function due to chronic
rejection, she underwent combined
kidney-pancreas transplantation 5
years later, in 1990. Because of chron-
ic rejection, the patient lost the kidney
graft 5 years later, in 1995, and went
back on dialysis with a well-function-
ing pancreas graft. In 2004, the patient
was bitten on the right forearm by a
dog. She was on immunosuppressive
therapy of prednisolone (5 mg/day),
cyclosporine-A (trough levels of 100
ng/dL), and azathioprine (50 mg/day).
The initial lesion healed without
major complication. After several
days, a single firm edematous plaque
of 3 x 5 cm developed at the site of the
animal bite, and the patient was
admitted to the Department of
Dermatology. Empiric antimicrobial
combination therapy, including clin-
damycin (300 mg every 8 hours) and
ciprofloxacin (500 mg every 12
hours), was initiated. As no clinical
improvement was achieved, a biopsy
was performed, which showed a gran-
ulomatous inflammation with a high
number of mycobacteria (Figure).
Atypical mycobacteria were cultured
from a second biopsy (Löwenstein-
Jensen/Stonebrink, Heidelberg, Ger-
many); M. chelonae was identified by
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